Malta vs Mongolia: HIV-positive TB patients on ART (antiretroviral therapy)
Malta
100.0%
in 2023
Mongolia
100.0%
in 2024
Malta rank
1st
Mongolia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malta
- Mongolia
How they compare
Malta currently reports 100.0% against 100.0% in Mongolia, a difference of 0.0%.
The two have swapped places 4 times across 8 shared years of data; in 2006 it was Mongolia ahead.
Malta ranks 1st and Mongolia ranks 1st of 144 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 77.7% | 22.3% | Malta |
| 2010s | 100.0% | 87.5% | 12.5% | Malta |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malta or Mongolia?
- Malta, at 100.0% against 100.0% in Mongolia as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malta and Mongolia?
- 0.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Mongolia?
- 8 years are reported by both, from 2006 to 2023.
- How do Malta and Mongolia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malta ranks 1st and Mongolia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.